With soaring medical costs weighing heavily on the US economy, it's not surprising that obesity has become a target in the health care reform debate. Obesity is costly because it significantly increases the risk of many chronic diseases. Exercise, dieting and prescription drugs have had a limited effect in stemming the tide of obesity, leaving bariatric surgery and other interventional techniques as the primary treatment options for this potentially multi-billion dollar market. But device manufacturers have a challenge ahead of them--to develop more effective, safer, and less invasive obesity therapies that will not only result in long-term weight loss, but will also cut treatment costs and better manage comorbidities.
by Anne Staylor
With soaring medical costs weighing heavily on the US economy, it is not surprising that obesity has become a target in the health care reform debate. There is an undeniable...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
